Patents by Inventor Subhasish K. Chakraborty

Subhasish K. Chakraborty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9995679
    Abstract: Biosensor comprising an activatable acceptor fluorogen linked via a linker to a donor which transfers energy to the fluorogen on detecting an analyte wherein the fluorogen component reacts and a 100 fold increase in intensity results when the fluorogen interacts non-covalently with an activator e.g. fluorogen activator peptide.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: June 12, 2018
    Assignee: Carnegie Mellon University
    Inventors: Alan Waggoner, Marcel P. Bruchez, Brigitte F. Schmidt, Subhasish K. Chakraborty
  • Patent number: 9023998
    Abstract: Tissue slices and whole organisms offer substantial challenges to fluorescence imaging. Autofluorescence and absorption via intrinsic chromophores, such as flavins, melanin, and hemoglobins, confound and degrade output from all fluorescent tags. An “optical window,” farther red than most autofluorescence sources and in a region of low hemoglobin and water absorbance, lies between 650 and 900 nm. This valley of relative optical clarity is an attractive target for fluorescence-based studies within tissues, intact organs, and living organisms. Novel fluorescent tags were developed herein, based upon a genetically targeted fluorogen activating protein and cognate fluorogenic dye that yields emission with a peak at 733 nm exclusively when complexed as a “fluoromodule”. This tool improves substantially over previously described far-red/NIR fluorescent proteins in terms of brightness, wavelength, and flexibility by leveraging the flexibility of synthetic chemistry to produce novel chromophores.
    Type: Grant
    Filed: June 18, 2013
    Date of Patent: May 5, 2015
    Assignee: Carnegie Mellon University
    Inventors: Subhasish K. Chakraborty, Mingrui Zhang, Alan S. Waggoner
  • Publication number: 20140243509
    Abstract: Tissue slices and whole organisms offer substantial challenges to fluorescence imaging. Autofluorescence and absorption via intrinsic chromophores, such as flavins, melanin, and hemoglobins, confound and degrade output from all fluorescent tags. An “optical window,” farther red than most autofluorescence sources and in a region of low hemoglobin and water absorbance, lies between 650 and 900 nm. This valley of relative optical clarity is an attractive target for fluorescence-based studies within tissues, intact organs, and living organisms. Novel fluorescent tags were developed herein, based upon a genetically targeted fluorogen activating protein and cognate fluorogenic dye that yields emission with a peak at 733 nm exclusively when complexed as a “fluoromodule”. This tool improves substantially over previously described far-red/NIR fluorescent proteins in terms of brightness, wavelength, and flexibility by leveraging the flexibility of synthetic chemistry to produce novel chromophores.
    Type: Application
    Filed: June 18, 2013
    Publication date: August 28, 2014
    Inventors: Subhasish K. Chakraborty, Mingrui Zhang, Alan S. Waggoner
  • Publication number: 20130244891
    Abstract: Biosensor comprising an activatable acceptor fluorogen linked via a linker to a donor which transfers energy to the fluorogen on detecting an analyte wherein the fluorogen component reacts and a 100 fold increase in intensity results when the fluorogen interacts non-covalently with an activator e.g. fluorogen activator peptide.
    Type: Application
    Filed: May 25, 2011
    Publication date: September 19, 2013
    Applicant: CARNEGIE MELLON UNIVERSITY
    Inventors: Alan Waggoner, Marcel P. Bruchez, Brigitte F. Schmidt, Subhasish K. Chakraborty
  • Patent number: 7282606
    Abstract: The present invention discloses a new process for the synthesis of tamsulosin and its aralkylamine derivatives, especially (R)-(?)-5-{2-[2-(2-alkoxyphenoxy) ethylamino]propyl}-2-alkoxybenzenesulfonamides having the following formula 1 (where R1 and R2 represent C1-C4 alkyl groups) and their hydrochloride thereof, and other various pharmaceutical used salts. Tamsulosin hydrochloride (R1=Et, R2=Me, in its hydrochloride salt form) is an antagonist of ?-A adrenoceptors in the prostate. Tamsulosin•HCl occurs as white crystals, which melt with decomposition at approximately 230° C. It is sparingly soluble in water and in methanol, slightly soluble in glacial acetic acid and in ethanol, and practically insoluble in ether.
    Type: Grant
    Filed: July 13, 2005
    Date of Patent: October 16, 2007
    Assignees: Well-Being Biochemical Corp., Taiwan Biotech Co., Ltd.
    Inventors: Ru Hwu Jih, Shwu Chen Tsay, Balaachary Magendran, Subhasish K. Chakraborty, Asish R. Das, Kuen Wang Sheu, Chun Mei Shu, Chin Kun Lu, Wei Min Chang